SERENDIP INNOVATIONS Trademark

Trademark Overview


On Friday, November 15, 2024, a trademark application was filed for SERENDIP INNOVATIONS with the United States Patent and Trademark Office. The USPTO has given the SERENDIP INNOVATIONS trademark a serial number of 79414532. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 9, 2025. This trademark is owned by Serendip Innovations SAS. The SERENDIP INNOVATIONS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, medical and veterinary preparations; medicines for human medicine; remedies for human medicine; serotherapeutic medicines; anti-cancer medicines; immunosuppressive medicines; immunomodulator medicines; anti-inflammatory medications; tonics [medicines]; vaccines; vaccines for human use; vaccines for the treatment of cancer; cellular function activating agents for medical purposes; drug and pharmaceutical delivery agents; cachets for medicinal use; tablets for pharmaceutical use; biopharmaceutical products for cancer treatment; pharmaceutical preparations for use in oncology; pharmaceuticals for the treatment of inflammatory diseases; biological preparations for the treatment of cancer; immunotherapeutic agents for bacterial infections; antibodies; human immunoglobulin; immune modulators; immunostimulants; pharmaceuticals for use in oncology, immunology, intensive medicine, transplantation medicine and for influencing the immune system; pharmaceuticals for the pr...

Scientific and technological services as well as research and design services relating thereto; clinical trials; research and development service in the field of chemistry, biology and biochemistry; research and development services in the field of oncology; research and development services in the field of cancerous diseases; research and development services in the field of immunology; research and development services in the field of vaccinology; research and development services in the field of bacteriology and virology; research and development services in the field of antibody technology; research and development in the field of antibodies; research and development services in the field of animal health; technical project study services in the field of chemistry, biology and biochemistry; technical project study services in oncology, immunology and vaccinology; biological research; research in bacteriology and virology; technical project study services in the field of animal heal...
serendip innovations

General Information


Serial Number79414532
Word MarkSERENDIP INNOVATIONS
Filing DateFriday, November 15, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, January 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products, medical and veterinary preparations; medicines for human medicine; remedies for human medicine; serotherapeutic medicines; anti-cancer medicines; immunosuppressive medicines; immunomodulator medicines; anti-inflammatory medications; tonics [medicines]; vaccines; vaccines for human use; vaccines for the treatment of cancer; cellular function activating agents for medical purposes; drug and pharmaceutical delivery agents; cachets for medicinal use; tablets for pharmaceutical use; biopharmaceutical products for cancer treatment; pharmaceutical preparations for use in oncology; pharmaceuticals for the treatment of inflammatory diseases; biological preparations for the treatment of cancer; immunotherapeutic agents for bacterial infections; antibodies; human immunoglobulin; immune modulators; immunostimulants; pharmaceuticals for use in oncology, immunology, intensive medicine, transplantation medicine and for influencing the immune system; pharmaceuticals for the prevention and treatment of viral diseases; pharmaceuticals for the treatment of diseases of the immune system; pharmaceuticals for the treatment of oncological diseases; biological preparations for medical use; mixed biological preparations for medical use; biochemical preparations for medical use; chemical-pharmaceutical preparations; chemical preparations for medical use; preparations of micro-organisms for medical use; phytotherapy preparations for medical use; diagnostic preparations for medical use; medical preparations; medicinal preparations; medicinal health care preparations; preparations for oral vaccination; medical and pharmaceutical substances and preparations used in oncology; medical and pharmaceutical substances and preparations used in immunology; reagents for medical use; chemical reagents for medical use; diagnostic biomarking reagents for medical use; anti-inflammatories; antibiotics; biological tissue cultures for medical use; elixirs [pharmaceutical preparations]; enzymes for medical use.
Goods and ServicesScientific and technological services as well as research and design services relating thereto; clinical trials; research and development service in the field of chemistry, biology and biochemistry; research and development services in the field of oncology; research and development services in the field of cancerous diseases; research and development services in the field of immunology; research and development services in the field of vaccinology; research and development services in the field of bacteriology and virology; research and development services in the field of antibody technology; research and development in the field of antibodies; research and development services in the field of animal health; technical project study services in the field of chemistry, biology and biochemistry; technical project study services in oncology, immunology and vaccinology; biological research; research in bacteriology and virology; technical project study services in the field of animal health; research in chemistry, biology and biochemistry; research in oncology, immunology and vaccinology; medical research; medical research in the field of oncology; medical research in the field of immunology; medical research in the field of vaccinology; biomedical research; scientific research conducted using databases; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the field of immunology; scientific research for medical purposes in the field of vaccinology; scientific research for medical purposes in the field of virology and bacteriology; technical research; chemical, biological and biochemical technology research; clinical research; research in the field of medicine; research in the field of medicines; technical writing; chemistry, biology and biochemistry services; scientific laboratory services; scientific research services; scientific research services for medical purposes; medical and pharmacological research services; research laboratory; research and development in the field of biotechnology; research and development in the field of oncology, immunology and vaccinology; scientific testing services; carrying out clinical trials; scientific services and research services relating thereto; scientific services and design services relating thereto; medical and pharmacological research services; advisory services relating to research and development in the field of therapeutics; medicine discovery services; development of pharmaceutical preparations and medicines; developing gene-based, antigen-based medicines; research and development of vaccines and medicines; research and development services with respect to vaccines; research and development of medicines; research and development of siRNA-based medicines; provision of information concerning the results of clinical trials for pharmaceutical products; Provision of information and data relating to medical research and development; laboratory analyses in the field of chemistry, biology and biochemistry; scientific research and analysis; design and development of medical technologies; conducting of technical project studies; providing scientific research services; preparing project analysis studies; preparation of technical surveys; preparation of reports concerning scientific research; preparation of scientific reports; carrying out technical feasibility studies; Research in the field of bioengineering; information service concerning scientific research; scientific information service; industrial analysis and research services in the field of chemistry, biology and biochemistry; laboratory testing services; scientific design service; consultant services in the field of scientific research; advice relating to scientific research; scientific advisory services; human and animal health medicine discovery services; development of testing methods; vaccine discovery services.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 9, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 9, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSerendip Innovations SAS
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressFR

Trademark Events


Event DateEvent Description
Thursday, January 9, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB